An underground economy for unapproved slimming drugs is being driven by social media fitness personalities and vendors on messaging platforms, according to recent findings.
Experimental Drug Gaining Popularity Online
The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its alleged fat-burning properties. Followers are encouraged to message these accounts directly for supplier links, while also receiving discount codes.
Thriving Trade on Messaging Platforms
Separately, a flourishing market exists on Telegram, where communities with thousands of participants share comparison images, injection guides and assertions of next-day British shipping. Sellers promote the drug there before directing buyers to other platforms for transactions.
Understanding The Experimental Drug
Retatrutide is an investigational injectable created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help patients lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed online as the next Ozempic.
Medical Experts Voice Concerns
However, physicians and chemists have warned that the distribution of what is still an unlicensed medication in the UK is worrisome and could lead to users administering products of unknown origin.
Several professionals stated the popularity for the experimental drug could be connected to the increasing price of licensed weight loss products such as Mounjaro.
Legal Position and Implementation
Marketing retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be promoted or distributed for human use under the Human Medicines Regulations 2012.
Some content creators attempt to circumvent the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and supply can still violate medicines, advertising, and consumer laws, risking fines, legal action or prison.
Platform Reaction and Material Elimination
According to the social media company, the service has removed violative material and prohibited associated hashtags and query recommendations. The organization said it was committed to keeping the platform secure and investing in strengthening compliance measures.
Digital Trading Operations
Research also found groups with up to 9,000 members marketing the experimental drug using the platform's integrated search feature, which operates like a public directory. Entering “retatrutide” immediately brings up channels with numerous of users, filled with photos of weight loss, positive reviews and detailed instructions for preparing or injecting at home.
Within moments of entering one group, a vendor posted WhatsApp details, where most transactions take place. The seller provided an guidebook and guaranteed delivery within 48 hours. When questioned whether the product was genuine, one seller said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None inquired about body mass, medical conditions or previous experience.
Item Information and Pricing
Within these communities, posts display dark colored packages with Royal Mail stickers, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, prepared at residence with purified liquid, or pre-filled pens usually priced at £160 for 20 milligrams. When asked how much time a injector should last, vendors give contradictory answers ranging from a few weeks to “depends on your body”.
Service Moderation and Security Measures
A spokesperson for the messaging service stated it actively moderated harmful material on its service including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“People are injecting substances they can’t verify. Although the research behind this drug is valid, these online versions may not contain what they advertise,” stated a pharmacy expert, the head of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of an online medical service connected the increase in demand to current price rises for approved weight-loss medications such as Mounjaro. “With prices rising, patients are using online platforms. But counterfeit injections are extremely dangerous. You can’t be certain what’s contained or whether the environment they were made in was sterile,” she explained.
Her staff has already encountered patients injured by personal administration from unverified sources. “We recognize the disappointment, but buying from messaging apps or WhatsApp is taking chances with your health,” stated Wyllie. “These substances could be impure or incorrectly dosed.”
Producer Position
A representative from Eli Lilly said the substance was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can market [it] for human use,” they said, noting that any item “falsely representing itself as a company experimental product not yet approved … may expose patients to potentially significant health risks”.
